Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 15,290 | 14,179 | 13,331 | 13,601 | 9,450 |
| Operating Income | -15,290 | -14,179 | -13,331 | -13,601 | -9,450 |
| Other Income | 196 | 86 | 92 | 39 | 3,270 |
| Pre-tax Income | -15,094 | -14,093 | -13,239 | -13,562 | -6,180 |
| Net Income Continuous | -15,094 | -14,093 | -13,239 | -13,562 | -6,180 |
| Net Income | $-15,094 | $-14,093 | $-13,239 | $-13,562 | $-6,180 |
| EPS Basic Total Ops | -228.23 | -552.55 | -1,570.57 | -3,213.21 | -6,426.43 |
| EPS Basic Continuous Ops | -228.78 | -551.41 | -1,342.24 | -2,902.62 | -4,250.32 |
| EPS Diluted Total Ops | -228.23 | -552.55 | -1,570.57 | -3,213.21 | -6,426.43 |
| EPS Diluted Continuous Ops | -228.78 | -551.41 | -1,342.24 | -2,902.62 | -4,250.32 |
| EPS Diluted Before Non-Recurring Items | -228.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-15,149 | $-14,046 | $-11,573 | $-12,055 | $-9,093 |